About this episode

This episode discusses the interpretation of abnormal SPEP results and the clinical significance of MGUS.

Monoclonal gammopathy of undetermined significance (MGUS) is a common but often confusing finding on serum protein electrophoresis (SPEP) reports. In this HemeTalks episode, Drs. Rahma Warsame and Jason Chen discuss how to interpret abnormal SPEP results, evaluate patients with suspected MGUS, and differentiate between benign and concerning findings. Using real-world cases, they highlight key clinical decision points, follow-up strategies, and how to communicate results with patients effectively. Tune in for expert guidance on navigating this diagnostic gray zone in hematology. Learning Objectives: Recognize the clinical significance of MGUS and how it is detected Understand how to interpret MGUS lab testing results in the context of monoclonal gammopathies Identify when to refer, monitor, or investigate further in patients with MGUS Clinical Pearls: MGUS is a premalignant condition that is a diagnosis of exclusion. It is defined by the presence of a serum monoclonal protein (M-protein) less than 3 g/dL, bone marrow plasma cellsl <10%, and no end organ damage (CRAB) MGUS can progress to multiple myeloma, AL amyloidosis, Waldenstrom’s macroglobulinemia Confirmatory tests for…

People in this episode

Guests: Rahma Warsame, Jason Chen

Topics covered

• MGUS
• serum protein electrophoresis
• hematology
• clinical decision making
• patient communication

Keywords

• MGUS
• serum monoclonal protein
• bone marrow plasma cells
• multiple myeloma
• diagnostic gray zone

Mentioned in this episode

Organizations: American Society of Hematology

Books & works: Interpreting Abnormal SPEP – Is It Just MGUS?

More episodes of HemeTalks: Conversations in Hematology Education

• Approaching MDS: Advances in Diagnostics, Therapeutics and Monitoring · April 16, 2026 · 25 min
• New Horizons in Smoldering Multiple Myeloma · March 19, 2026 · 26 min
• Sticky Situations: The Role of Thrombophilia Testing in VTE Management · January 15, 2026 · 28 min
• Lost in Translation: The aHUS Experience · December 18, 2025 · 20 min
• Inclusion of those with those with Duffy-null Associated Neutrophil Count (DANC) in Clinical Trials · November 20, 2025 · 26 min
• Thalassemia in Pediatric Hematology · October 16, 2025 · 19 min

Explore listener stats, chart rankings, contacts and more on the HemeTalks: Conversations in Hematology Education podcast page.